The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: The Motley Fool
Dividends are really good. Dividends that keep coming every year are great. But dividends that keep growing There's a category of stocks that delivers such fantastic dividends. Dividend Aristocrats are companies in the 00 that have increased their dividends annually for at least consecutive years. Only 7 companies are currently on the list. Some of these dividend-hiking stocks are better than others. But I think that the best Dividend Aristocrat you can buy right now is Abbot Laboratories ( NYSE:ABT Image source: Getty Images. A rock-solid business What I like the most about Abbott Labs is that it's simply a great company with a rock-solid business. Abbott ranks as one of the biggest healthcare stocks Abbott's medical devices segment rakes in the most money, with sales of more than $. billion in 09. This unit develops and markets a wide range of products, including cardiac monitors, diabetes-care devices, heart ablation catheters, heart valve clips, neuromodulation devices, and sten
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- 2 Dividend Kings to Buy for a Lifetime of Passive Income [Yahoo! Finance]Yahoo! Finance
- Smart Medical Devices Business Research Report 2024-2030 - Rising Demand for AI-Driven Diagnostics, Self-Tracking, and Digital Therapeutics Generates Market Opportunities [Yahoo! Finance]Yahoo! Finance
- Blood Cancer Diagnostics Market to hit USD 22.2 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Embolotherapy Business Research Report 2024-2030: Shift Toward Outpatient and Ambulatory Care Settings for Embolotherapy Procedures Expands Access and Drives Cost-Effective Healthcare Delivery [Yahoo! Finance]Yahoo! Finance
- Endocrinology Drugs Market Analysis by Therapy Area, Distribution Channel and Region - A Forecasted $53.85 Billion Industry by 2030 [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website